Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2015

Oct 7, 2015

32566_dirs_2015-10-07_8a6d11d5-f4eb-4000-9a48-e074a519d4e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-09-02

Reporting Person: MARSH RICHARD M (E.V.P., General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-09-02 Common Stock G 1000.0 $0.0 Disposed 73227 Direct
2015-10-06 Common Stock M 1.0 $16.53 Acquired 66544 Direct
2015-10-06 Common Stock M 2346.0 $30.12 Acquired 68890 Direct
2015-10-06 Common Stock M 3861.0 $30.34 Acquired 72751 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-06 Incentive Stock Option (right to buy) $16.53 M 1.0 Disposed 2020-09-15 Common Stock (1) Direct
2015-10-06 Incentive Stock Option (right to buy) $30.12 M 2346.0 Disposed 2019-02-18 Common Stock (2346) Direct
2015-10-06 Incentive Stock Option (right to buy) $30.34 M 3861.0 Disposed 2019-09-15 Common Stock (3861) Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.